Navigation Links
Forge Therapeutics Scientific Co-Founder Bestowed Prestigious National Chemistry Award
Date:8/19/2015

SAN DIEGO, Aug. 19, 2015 /PRNewswire/ -- Forge Therapeutics, Inc., a biotechnology start-up developing novel small molecule inhibitors that target metalloproteins announced today Dr. Seth Cohen, Ph.D., co-founder of Forge Therapeutics and Professor in the Department of Chemistry and Biochemistry at the University of California, San Diego is the recipient of the Arthur C. Cope Scholar Award administered by the American Chemical Society. 

The Arthur C. Cope Scholar Award is a prize awarded for excellence and achievement in the field of organic chemistry.  Dr. Cohen was named one of the ten Arthur C. Cope Scholars at the American Chemical Society national meeting being held in Boston from August 16-20, 2015 for his pioneering work on metalloprotein chemistry. 

"It is with great pride at Forge Therapeutics that we congratulate Dr. Cohen on being named an Arthur C. Cope Scholar," said Zachary A. Zimmerman, Ph.D., CEO of Forge Therapeutics.  "This award is a high honor in the field of chemistry and further validates the Forge Therapeutics drug discovery platform."

To learn more about the Arthur C. Cope Scholar Award please visit: http://www.acs.org/content/acs/en/funding-and-awards/awards/national/recipients/2016-national-award-recipients.html

About Forge Therapeutics, Inc.

Forge Therapeutics, Inc. ("Forge") is a biotechnology start-up that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins.  Metalloproteins are proteins that require metal ions for their biological function and make up over 1/3 of the proteins in the human body.  Forge uses a proprietary approach comprised of molecular modeling for rational drug design along with fundamental knowledge and expertise in bioinorganic chemistry to target metalloproteins.  Forge is uniquely positioned to discover compounds that inhibit metalloproteins through an innovative process developed at the University of California at San Diego.  Forge possesses rights to key intellectual property for metalloprotein inhibitors. The name Forge Therapeutics comes from two definitions for forge: to manipulate (inhibit) a metal object (metalloprotein) and to move forward steadily with a purpose (the Forge team).  Forge Therapeutics, Inc., maintains its headquarters in San Diego, California.  To learn more please visit www.ForgeTherapeutics.com

Contact:
Info@ForgeTherapeutics.com

Logo - http://photos.prnewswire.com/prnh/20150807/256906LOGO


'/>"/>
SOURCE Forge Therapeutics, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Forge Therapeutics Co-Founder to Present at the 250th American Chemical Society National Meeting
2. Forge Therapeutics Enters Into a Pilot Study with Janssen Research & Development, LLC, to Discover Novel Metalloprotein Inhibitors
3. Genedata and IntelliCyt Forge Alliance to Transform Cell-based Screening in Drug Discovery
4. Bynder and HubCast Forge Global Partnership for Transformative “Concept to Delivery” Solution
5. Never forget a face
6. Tor/Forge Launches THE CURE, a Riveting Thriller in the Tradition of Michael Crichton, by the New York Times Bestselling Author of WIRED.
7. Don't Forget the Payer in Your Digital Strategy: What Payers Need and Want from Pharma
8. Chrysalis BioTherapeutics TP508 Reverses Radiation-Induced GI Damage
9. PTC Therapeutics Announces Closing of $150 Million of Convertible Senior Notes
10. Echo Therapeutics, Inc. Provides Corporate Update and Announces Second Quarter 2015 Financial Results
11. BrainStorm Cell Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... Baltimore biotech firm, PathSensors, ... to bring its proprietary CANARY pathogen detection technology and high throughput testing solutions ... has purchased an undisclosed number of PathSensors’ Zephyr pathogen detection instruments and will ...
(Date:8/18/2017)... ... August 18, 2017 , ... Producers of the ... Hybrids, Inc. in an upcoming episode, scheduled to broadcast fourth quarter 2017. American ... Federal Hybrids, the independent, family-owned seed company. Educating audiences about its broad portfolio ...
(Date:8/16/2017)... ... , ... Tunnell Consulting announced today that four of the firm’s ... and Expo , to be held October 29 through November 1 in San Diego ... advance patient therapies.” , The ISPE Annual Meeting and Expo will feature several interactive ...
(Date:8/16/2017)... ... 2017 , ... Today, 3Bar Biologics Inc ., the ... funding from an impressive group of investors, including Rev1 Ventures, Maumee Ventures, Ohio ... investment, 3Bar is broadening availability of its groundbreaking offering that uses naturally occurring ...
Breaking Biology Technology:
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
(Date:3/22/2017)... -- Vigilant Solutions , a vehicle location and ... today the appointment of retired FBI special agent ... development. Mr. Sheridan brings more than 21 ... on the aviation transportation sector, to his new role ... served as the Aviation Liaison Agent Coordinator (ALAC) in ...
Breaking Biology News(10 mins):